These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 6356457)

  • 1. Des-amino-D-arginine vasopressin does not increase circulating levels of prostacyclin or thromboxane A2 during infusion in man.
    Barrow SE; Heavey DJ; Jacqz E; Blair IA; Dollery CT
    Thromb Haemost; 1983 Aug; 50(2):622. PubMed ID: 6356457
    [No Abstract]   [Full Text] [Related]  

  • 2. [Changes of thromboxane A2 and prostacyclin in the pregnant hypertensive syndrome].
    Shen XY
    Zhonghua Yi Xue Za Zhi; 1984 Dec; 64(12):735-7, 790. PubMed ID: 6443193
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of des-amino-D-arginine vasopressin (DDAVP) on plasma levels of platelet and endothelial cell release products.
    D'Angelo A; Capitanio A; Smith JB; Valsecchi C; Mannucci PM
    Thromb Haemost; 1983 Feb; 49(1):64-5. PubMed ID: 6687766
    [No Abstract]   [Full Text] [Related]  

  • 4. [Kinetics of thromboxane A2 and prostacyclin during reperfusion after induced ischemia in canine hearts].
    Nomura F; Hirose H; Matsuda H; Nakano S; Shirakura R; Ohtani M; Kaneko M; Sasako Y; Kawashima Y; Kuzuya T
    Kyobu Geka; 1985 Jan; 38(1):46-9. PubMed ID: 3884863
    [No Abstract]   [Full Text] [Related]  

  • 5. Lipid peroxides, prostacyclin, and thromboxane A2 in runners during acute exercise.
    Viinikka L; Vuori J; Ylikorkala O
    Med Sci Sports Exerc; 1984 Jun; 16(3):275-7. PubMed ID: 6379367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of intravenous infusion of OKY-1581 (sodium-(E)-3-[4-(3-pyridylmethyl)phenyl] -2-methylacrylate) on circulatory thromboxane A2 and prostacyclin levels in anaesthetized baboon.
    Roy AC; Adaikan PG; Karim SM
    Prostaglandins Med; 1981 Sep; 7(3):253-9. PubMed ID: 7029585
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of cytostatics on prostaglandin F2 alpha prostacyclin, and thromboxane in patients with gynecologic malignancies.
    Ylikorkala O; Kauppila A; Viinikka L
    Obstet Gynecol; 1981 Oct; 58(4):483-6. PubMed ID: 7024882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating prostacyclin and thromboxane levels in patients with diabetic retinopathy.
    Lane LS; Jansen PD; Lahav M; Rudy C
    Ophthalmology; 1982 Jul; 89(7):763-6. PubMed ID: 6750495
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The role of prostacycline, thromboxane A2 and prostaglandins in platelet aggregation (author's transl)].
    Herman AG
    Rev Med Brux; 1981 Mar; 2(3):251-7. PubMed ID: 7015444
    [No Abstract]   [Full Text] [Related]  

  • 10. Prostacyclin and thromboxane A2 formation in response to adrenergic stimulation in humans: a mechanism for local control of vascular response to sympathetic activation?
    Serneri GG; Masotti G; Gensini GF; Poggesi L; Abbate R; Mannelli M
    Cardiovasc Res; 1981 May; 15(5):287-95. PubMed ID: 7028264
    [No Abstract]   [Full Text] [Related]  

  • 11. [Biochemistry of coronary artery disease--prostaglandins].
    Tada M; Kuzuya T; Ohmori M
    Rinsho Byori; 1983 Aug; 31(8):854-9. PubMed ID: 6361336
    [No Abstract]   [Full Text] [Related]  

  • 12. [Blood thromboxane A2 and prostaglandin I2 levels and platelet phospholipid fatty acid composition ratios in ischemic heart disease and cerebral infarction--with special reference to the effect of antiplatelet agents].
    Inoue T
    Nihon Ronen Igakkai Zasshi; 1983 Jul; 20(4):294-304. PubMed ID: 6363769
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of arginine vasopressin and 1-desamino-8-D arginine vasopressin on forearm vasculature of healthy subjects and patients with a V2 receptor defect.
    van Lieburg AF; Knoers NV; Monnens LA; Smits P
    J Hypertens; 1995 Dec; 13(12 Pt 2):1695-700. PubMed ID: 8903635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DDAVP stimulates prostacyclin production.
    Belch JJ; Small M; McKenzie F; Hill PA; Lowe GD; McIntyre DE; Forbes CD; Prentice CR
    Thromb Haemost; 1982 Apr; 47(2):122-3. PubMed ID: 6808693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thromboxane, prostaglandin I2 (epoprostenol), and the hemodynamic changes in equine endotoxin shock.
    Bottoms GD; Templeton CB; Fessler JF; Johnson MA; Roesel OF; Ewert KM; Adams SB
    Am J Vet Res; 1982 Jun; 43(6):999-1002. PubMed ID: 7049018
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The effect of x-ray contrast media on the amount of thromboxane and prostacyclin in the blood of man and rats in vivo and in vitro].
    Napolov IuK; Shimanovskiĭ NL; Bolotova EN; Borsukova NM; Sergeev PV
    Eksp Klin Farmakol; 1993; 56(5):41-3. PubMed ID: 8312809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of sodium selenite supplementation on the levels of prostacyclin I(2) and thromboxane A(2) in human.
    Abdulah R; Katsuya Y; Kobayashi K; Nakazawa M; Nara M; Murakami M; Koyama H
    Thromb Res; 2007; 119(3):305-10. PubMed ID: 16564072
    [No Abstract]   [Full Text] [Related]  

  • 18. Thromboxanes and ischaemic vascular disease.
    Hornstra G
    Neth J Med; 1982; 25(1):6-14. PubMed ID: 7035978
    [No Abstract]   [Full Text] [Related]  

  • 19. [Status of the prostacyclin-thromboxane A2 system in patients with ischemic heart disease during induced myocardial ischemia].
    Nikolaeva LF; Aleshin OI; Pavlov NA; Pomerantsev EV; Masenko VP
    Sov Med; 1988; (4):3-6. PubMed ID: 3043710
    [No Abstract]   [Full Text] [Related]  

  • 20. Maternal thromboxane, prostacyclin, and umbilical blood flow in humans.
    Ylikorkala O; Jouppila P; Kirkinen P; Viinikka L
    Obstet Gynecol; 1984 May; 63(5):677-80. PubMed ID: 6546976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.